⌘K

Login Start Free

Home/Filings/4/0001209191-22-007789

4//SEC Filing

Fairman Jeff 4

Accession 0001209191-22-007789

CIK 0001649094other

View on SEC.gov Company Profile

Filed

Feb 7, 7:00 PM ET

Accepted

Feb 8, 5:27 PM ET

Size

8.3 KB

Accession

0001209191-22-007789

Insider Transaction Report

Form 4

Period: 2021-12-20

Vaxcyte, Inc.PCVX

VP, Research

Transactions

Exercise/Conversion
Common Stock
2021-12-20$1.79/sh+4,469$8,000→ 10,629 total
Exercise/Conversion
Stock Option (right to buy)
2021-12-20−4,469→ 53,626 total
Exercise: $1.79Exp: 2027-05-17→ Common Stock (4,469 underlying)

Holdings

Common Stock
(indirect: By Trust)
50,000
Common Stock
(indirect: By Trust)
341,227

Footnotes (1)

[F1]The shares subject to the option are fully vested and exercisable.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Vaxcyte, Inc.

CIK 0001649094

Entity typeother

Related Parties

1

filerCIK 0001813800

Filing Metadata

Form type: 4
Filed: Feb 7, 7:00 PM ET
Accepted: Feb 8, 5:27 PM ET
Size: 8.3 KB

View on SEC.gov